Potential repurposing of oncology drugs for the treatment of Alzheimer's disease
- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
1741-7015
- Umfang
-
Online-Ressource
- Sprache
-
Englisch
- Anmerkungen
-
online resource.
- Erschienen in
-
Potential repurposing of oncology drugs for the treatment of Alzheimer's disease ; volume:11 ; number:1 ; day:26 ; month:3 ; year:2013 ; pages:1-3 ; date:12.2013
BMC medicine ; 11, Heft 1 (26.3.2013), 1-3, 12.2013
- Urheber
-
Araki, Wataru
- Beteiligte Personen und Organisationen
-
SpringerLink (Online service)
- DOI
-
10.1186/1741-7015-11-82
- URN
-
urn:nbn:de:1111-2016072226494
- Rechteinformation
-
Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Letzte Aktualisierung
-
14.08.2025, 10:56 MESZ
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Beteiligte
- Araki, Wataru
- SpringerLink (Online service)
Ähnliche Objekte (12)
Drug Repurposing in Oncology
In silico repurposing of antipsychotic drugs for Alzheimer’s disease
Single-cell-led drug repurposing for Alzheimer’s disease
Drug repurposing
Repurposing of approved cardiovascular drugs
Scaffold Searching of FDA and EMA-Approved Drugs Identifies Lead Candidates for Drug Repurposing in Alzheimer’s Disease
PATH-SURVEYOR: pathway level survival enquiry for immuno-oncology and drug repurposing
Artificial intelligence framework identifies candidate targets for drug repurposing in Alzheimer’s disease
Drug repurposing in cardiology
Applications of Artificial Intelligence in Drug Repurposing
Repurposing approved non-oncology drugs for cancer therapy: a comprehensive review of mechanisms, efficacy, and clinical prospects
Network analysis-guided drug repurposing strategies targeting LPAR receptor in the interplay of COVID, Alzheimer’s, and diabetes
Drug Repurposing in Oncology
In silico repurposing of antipsychotic drugs for Alzheimer’s disease
Single-cell-led drug repurposing for Alzheimer’s disease
Drug repurposing
Repurposing of approved cardiovascular drugs
Scaffold Searching of FDA and EMA-Approved Drugs Identifies Lead Candidates for Drug Repurposing in Alzheimer’s Disease
PATH-SURVEYOR: pathway level survival enquiry for immuno-oncology and drug repurposing
Artificial intelligence framework identifies candidate targets for drug repurposing in Alzheimer’s disease
Drug repurposing in cardiology
Applications of Artificial Intelligence in Drug Repurposing
Repurposing approved non-oncology drugs for cancer therapy: a comprehensive review of mechanisms, efficacy, and clinical prospects
Network analysis-guided drug repurposing strategies targeting LPAR receptor in the interplay of COVID, Alzheimer’s, and diabetes
Drug Repurposing in Oncology
In silico repurposing of antipsychotic drugs for Alzheimer’s disease
Single-cell-led drug repurposing for Alzheimer’s disease
Drug repurposing
Repurposing of approved cardiovascular drugs
Scaffold Searching of FDA and EMA-Approved Drugs Identifies Lead Candidates for Drug Repurposing in Alzheimer’s Disease
PATH-SURVEYOR: pathway level survival enquiry for immuno-oncology and drug repurposing
Artificial intelligence framework identifies candidate targets for drug repurposing in Alzheimer’s disease
Drug repurposing in cardiology
Applications of Artificial Intelligence in Drug Repurposing
Repurposing approved non-oncology drugs for cancer therapy: a comprehensive review of mechanisms, efficacy, and clinical prospects